Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: TRIM4

Gene summary for TRIM4

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

TRIM4

Gene ID

89122

Gene nametripartite motif containing 4
Gene AliasRNF87
Cytomap7q22.1
Gene Typeprotein-coding
GO ID

GO:0002376

UniProtAcc

Q9C037


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
89122TRIM4LZE20THumanEsophagusESCC1.71e-051.72e-010.0662
89122TRIM4LZE24THumanEsophagusESCC2.70e-184.06e-010.0596
89122TRIM4LZE21THumanEsophagusESCC4.17e-021.52e-010.0655
89122TRIM4P1T-EHumanEsophagusESCC7.49e-113.85e-010.0875
89122TRIM4P2T-EHumanEsophagusESCC8.99e-365.74e-010.1177
89122TRIM4P4T-EHumanEsophagusESCC1.50e-273.87e-010.1323
89122TRIM4P5T-EHumanEsophagusESCC6.28e-071.37e-010.1327
89122TRIM4P8T-EHumanEsophagusESCC3.13e-122.09e-010.0889
89122TRIM4P9T-EHumanEsophagusESCC1.63e-132.30e-010.1131
89122TRIM4P10T-EHumanEsophagusESCC1.30e-244.19e-010.116
89122TRIM4P11T-EHumanEsophagusESCC1.07e-144.24e-010.1426
89122TRIM4P12T-EHumanEsophagusESCC2.99e-295.69e-010.1122
89122TRIM4P15T-EHumanEsophagusESCC1.32e-387.19e-010.1149
89122TRIM4P16T-EHumanEsophagusESCC1.10e-498.42e-010.1153
89122TRIM4P17T-EHumanEsophagusESCC1.77e-123.78e-010.1278
89122TRIM4P19T-EHumanEsophagusESCC2.26e-104.13e-010.1662
89122TRIM4P20T-EHumanEsophagusESCC1.23e-357.51e-010.1124
89122TRIM4P21T-EHumanEsophagusESCC2.61e-132.82e-010.1617
89122TRIM4P22T-EHumanEsophagusESCC3.64e-152.09e-010.1236
89122TRIM4P23T-EHumanEsophagusESCC6.27e-408.50e-010.108
Page: 1 2 3 4 5 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:00316472ColorectumMSSregulation of protein stability103/3467298/187232.52e-113.49e-09103
GO:19033202ColorectumMSSregulation of protein modification by small protein conjugation or removal82/3467242/187237.49e-094.63e-0782
GO:00508212ColorectumMSSprotein stabilization68/3467191/187231.53e-088.81e-0768
GO:00313962ColorectumMSSregulation of protein ubiquitination70/3467210/187231.88e-078.26e-0670
GO:00313972ColorectumMSSnegative regulation of protein ubiquitination33/346783/187235.08e-061.40e-0433
GO:00002092ColorectumMSSprotein polyubiquitination72/3467236/187235.19e-061.42e-0472
GO:19033212ColorectumMSSnegative regulation of protein modification by small protein conjugation or removal36/346795/187237.10e-061.82e-0436
GO:00709361ColorectumMSSprotein K48-linked ubiquitination27/346765/187231.40e-053.18e-0427
GO:19033204ColorectumFAPregulation of protein modification by small protein conjugation or removal61/2622242/187232.36e-069.21e-0561
GO:00508214ColorectumFAPprotein stabilization51/2622191/187232.63e-069.96e-0551
GO:00709362ColorectumFAPprotein K48-linked ubiquitination24/262265/187233.42e-061.23e-0424
GO:00002093ColorectumFAPprotein polyubiquitination59/2622236/187234.53e-061.52e-0459
GO:00316474ColorectumFAPregulation of protein stability70/2622298/187236.60e-062.04e-0470
GO:00313964ColorectumFAPregulation of protein ubiquitination50/2622210/187239.03e-051.59e-0350
GO:00313974ColorectumFAPnegative regulation of protein ubiquitination23/262283/187237.96e-048.36e-0323
GO:19033214ColorectumFAPnegative regulation of protein modification by small protein conjugation or removal25/262295/187231.10e-031.06e-0225
GO:00508215ColorectumCRCprotein stabilization44/2078191/187231.77e-068.92e-0544
GO:19033205ColorectumCRCregulation of protein modification by small protein conjugation or removal51/2078242/187234.55e-061.87e-0451
GO:00313975ColorectumCRCnegative regulation of protein ubiquitination24/207883/187237.18e-062.67e-0424
GO:19033215ColorectumCRCnegative regulation of protein modification by small protein conjugation or removal26/207895/187239.16e-063.19e-0426
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
Page: 1 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
TRIM4SNVMissense_Mutationrs746597075c.369N>Gp.Ile123Metp.I123MQ9C037protein_codingtolerated(0.1)benign(0.013)TCGA-AC-A23H-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownPD
TRIM4SNVMissense_Mutationnovelc.1252G>Tp.Ala418Serp.A418SQ9C037protein_codingdeleterious(0.03)benign(0.171)TCGA-AN-A046-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
TRIM4SNVMissense_Mutationrs773415980c.1220G>Ap.Arg407Hisp.R407HQ9C037protein_codingtolerated(0.09)benign(0)TCGA-A6-6653-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownSD
TRIM4SNVMissense_Mutationc.663N>Tp.Leu221Phep.L221FQ9C037protein_codingdeleterious(0)probably_damaging(0.986)TCGA-AA-3510-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownSD
TRIM4SNVMissense_Mutationnovelc.1085G>Tp.Arg362Ilep.R362IQ9C037protein_codingdeleterious(0)benign(0.309)TCGA-AA-3984-01Colorectumcolon adenocarcinomaFemale<65I/IIUnknownUnknownSD
TRIM4SNVMissense_Mutationc.790C>Gp.Leu264Valp.L264VQ9C037protein_codingdeleterious(0.01)probably_damaging(0.952)TCGA-AA-A01K-01Colorectumcolon adenocarcinomaFemale>=65III/IVChemotherapyfolinicCR
TRIM4SNVMissense_Mutationnovelc.932N>Ap.Leu311Glnp.L311QQ9C037protein_codingdeleterious(0.05)benign(0.272)TCGA-AM-5820-01Colorectumcolon adenocarcinomaFemale<65I/IIUnknownUnknownSD
TRIM4SNVMissense_Mutationc.1030G>Ap.Ala344Thrp.A344TQ9C037protein_codingtolerated(0.15)probably_damaging(0.977)TCGA-WS-AB45-01Colorectumcolon adenocarcinomaFemale<65I/IIUnknownUnknownSD
TRIM4SNVMissense_Mutationnovelc.593G>Tp.Arg198Ilep.R198IQ9C037protein_codingdeleterious(0.04)probably_damaging(0.979)TCGA-AG-A002-01Colorectumrectum adenocarcinomaMale<65I/IIUnknownUnknownSD
TRIM4deletionFrame_Shift_Delc.1118delAp.Asn373ThrfsTer57p.N373Tfs*57Q9C037protein_codingTCGA-AA-3815-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
Page: 1 2 3 4 5 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1